Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation
Open Access
- 1 May 1988
- journal article
- case report
- Published by Oxford University Press (OUP)
- Vol. 64 (751) , 389-391
- https://doi.org/10.1136/pgmj.64.751.389
Abstract
Summary: This report describes a patient with chronic granulocytic leukaemia who developed cataracts on busulphan treatment. Following allogeneic bone marrow transplantation, he developed cytomegalovirus retinitis, which was treated successfully with trisodium phosphonoformate (foscarnet). Cytomegalovirus retinitis and its therapy, and busulphan-induced cataract are discussed.Keywords
This publication has 12 references indexed in Scilit:
- Treatment of CMV retinitis in an AIDS patient.British Journal of Ophthalmology, 1987
- Foscarnet for Cytomegalovirus RetinitisAnnals of Internal Medicine, 1985
- 9-(1,3-dihydroxy-2-propoxymethyl)guanine for Cytomegalovirus Infections in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- Treatment of Cytomegalovirus Retinitis with 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanineAnnals of Internal Medicine, 1985
- Acquired Immune Deficiency SyndromeOphthalmology, 1985
- Cytomegalovirus Infection and Specific Cell-Mediated Immunity after Marrow TransplantThe Journal of Infectious Diseases, 1980
- Cytomegalovirus retinitis in adultsThe American Journal of Medicine, 1977
- Epidemiology of Cytomegalovirus Infection after Transplantation and ImmunosuppressionThe Journal of Infectious Diseases, 1975
- Cataract after busulphan treatment.BMJ, 1972
- Lens Changes in Chronic Granulocytic LeukemiaAmerican Journal of Ophthalmology, 1969